KR101376471B1 - 디펩티딜 펩티다제-관련 질병 상태의 진단 및 예후 - Google Patents

디펩티딜 펩티다제-관련 질병 상태의 진단 및 예후 Download PDF

Info

Publication number
KR101376471B1
KR101376471B1 KR1020087024813A KR20087024813A KR101376471B1 KR 101376471 B1 KR101376471 B1 KR 101376471B1 KR 1020087024813 A KR1020087024813 A KR 1020087024813A KR 20087024813 A KR20087024813 A KR 20087024813A KR 101376471 B1 KR101376471 B1 KR 101376471B1
Authority
KR
South Korea
Prior art keywords
dpp
activity
measured
fractions
isoforms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020087024813A
Other languages
English (en)
Korean (ko)
Other versions
KR20090008218A (ko
Inventor
패트릭 오뮬란
크래이그 에이. 겔판드
Original Assignee
백톤 디킨슨 앤드 컴퍼니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 백톤 디킨슨 앤드 컴퍼니 filed Critical 백톤 디킨슨 앤드 컴퍼니
Publication of KR20090008218A publication Critical patent/KR20090008218A/ko
Application granted granted Critical
Publication of KR101376471B1 publication Critical patent/KR101376471B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
KR1020087024813A 2006-03-13 2007-03-13 디펩티딜 펩티다제-관련 질병 상태의 진단 및 예후 Active KR101376471B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US78192406P 2006-03-13 2006-03-13
US60/781,924 2006-03-13
US80439706P 2006-06-09 2006-06-09
US60/804,397 2006-06-09
US89276707P 2007-03-02 2007-03-02
US60/892,767 2007-03-02
PCT/US2007/006653 WO2007106595A1 (en) 2006-03-13 2007-03-13 Diagnosis and prognosis of dipeptidyl peptidase-associated disease states

Publications (2)

Publication Number Publication Date
KR20090008218A KR20090008218A (ko) 2009-01-21
KR101376471B1 true KR101376471B1 (ko) 2014-03-27

Family

ID=38265130

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087024813A Active KR101376471B1 (ko) 2006-03-13 2007-03-13 디펩티딜 펩티다제-관련 질병 상태의 진단 및 예후

Country Status (11)

Country Link
US (1) US8652789B2 (https=)
EP (1) EP1994415B9 (https=)
JP (1) JP5410955B2 (https=)
KR (1) KR101376471B1 (https=)
CN (1) CN101460851B (https=)
AU (1) AU2007225054B2 (https=)
BR (1) BRPI0708900A2 (https=)
CA (1) CA2645302C (https=)
ES (1) ES2549860T3 (https=)
MX (1) MX2008011665A (https=)
WO (1) WO2007106595A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2527649T3 (es) * 2007-12-10 2015-01-28 F. Hoffmann-La Roche Ag Panel de marcadores para el cáncer colorrectal
ES2533428T3 (es) * 2009-05-04 2015-04-10 F. Hoffmann-La Roche Ag Uso de DPPIV/Seprasa como un marcador para el cáncer
JP6065172B2 (ja) * 2010-10-22 2017-01-25 国立大学法人名古屋大学 微小血管障害又はその関連疾患のバイオマーカー
US20140273008A1 (en) * 2013-03-15 2014-09-18 Molecular Bioproducts, Inc. Methods to assess enzyme activity using mass spectrometric immunoassay
EP3314004A1 (en) * 2015-06-26 2018-05-02 DuPont Nutrition Biosciences ApS Aminopeptidases for protein hydrolyzates
AU2017252212B2 (en) * 2016-04-21 2023-09-07 4TEEN4 Pharmaceuticals GmbH Methods for determining DPP3 and therapeutic methods
CN110426518A (zh) * 2019-07-19 2019-11-08 宁波熙宁检测技术有限公司 一种定量检测人类血浆中dpp-4酶活性的方法
EP4308937B1 (en) * 2021-03-16 2026-02-04 Astrazeneca AB System and method for online detection of a post-translational modification of a polypeptide

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004104216A2 (en) * 2003-05-21 2004-12-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900662A (en) 1987-07-21 1990-02-13 International Immunoassay Laboratories, Inc. CK-MM myocardial infarction immunoassay
US5382515A (en) 1987-07-21 1995-01-17 International Immunoassay Laboratories, Inc. Creative kinase-MB immunoassay for myocardial infarction and reagents
US5382522A (en) 1987-07-21 1995-01-17 International Immunoassay Laboratories, Inc. Immunoassay for creatine kinase-MB and creatine kinase-BB isoforms and reagents
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004104216A2 (en) * 2003-05-21 2004-12-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)

Also Published As

Publication number Publication date
JP2009529884A (ja) 2009-08-27
AU2007225054A1 (en) 2007-09-20
CA2645302A1 (en) 2007-09-20
US8652789B2 (en) 2014-02-18
EP1994415B9 (en) 2015-12-16
ES2549860T3 (es) 2015-11-02
CA2645302C (en) 2017-07-11
JP5410955B2 (ja) 2014-02-05
CN101460851B (zh) 2016-09-21
EP1994415B1 (en) 2015-07-29
WO2007106595A1 (en) 2007-09-20
AU2007225054B2 (en) 2012-08-16
MX2008011665A (es) 2008-10-08
KR20090008218A (ko) 2009-01-21
EP1994415A1 (en) 2008-11-26
US20070264671A1 (en) 2007-11-15
CN101460851A (zh) 2009-06-17
BRPI0708900A2 (pt) 2011-06-14

Similar Documents

Publication Publication Date Title
KR101376471B1 (ko) 디펩티딜 펩티다제-관련 질병 상태의 진단 및 예후
Esteghamat et al. CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation
Craciun et al. RNA sequencing identifies novel translational biomarkers of kidney fibrosis
Miller et al. Current developments in salivary diagnostics
Manwaring et al. A metabolomic study to identify new globotriaosylceramide-related biomarkers in the plasma of Fabry disease patients
Aass et al. Comparative proteomic analysis of tear fluid in Graves' disease with and without orbitopathy
König et al. The serum protease network—one key to understand complex regional pain syndrome pathophysiology
DE60332538D1 (de) Oligosaccharid-biomarker für mucopolysaccharidosen und andere verwandte störungen
US20220381784A1 (en) Systems comprising substrates and methods of using the same for detection of pancreatic cancers
Byzia et al. Activity profiling of aminopeptidases in cell lysates using a fluorogenic substrate library
Trenchevska et al. Mass spectrometric immunoassay for quantitative determination of protein biomarker isoforms
Singh et al. Bedside procalcitonin and acute care
Öqvist et al. Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations
JP2013534315A (ja) ｃ−Ｓｒｃ選択反応モニタリングアッセイ
Portik-Dobos et al. Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes
Jimbo et al. Placenta increta: postpartum monitoring of plasma cell-free fetal DNA
Soluble Insulin Receptor Study Group Soluble insulin receptor ectodomain is elevated in the plasma of patients with diabetes
Parmar et al. Protein repertoire of human uterine fluid duringthe mid-secretory phase of the menstrual cycle
Dvir-Ginzberg et al. Chopping off the chondrocyte proteome
Falconer et al. The effect of endometriosis, cycle stage, lymphocyte suppression and pregnancy on CA-125 levels in peritoneal fluid and serum in baboons
Simmer et al. Kallikrein 4 is a secreted protein
RU2000119129A (ru) Молекула днк, кодирующая мутантный препронейропептид y, мутантный сигнальный пептид и их применения
EP3170001B1 (en) Viability assessment of in vitro cultured embryos from the culture medium
Patil et al. Role of lactoferrin in periodontal disease: A meta-analytical assessment of its reliability as a biomarker
Dikensoy et al. Association between urotensin II gene polymorphism and pre-eclampsia

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20081010

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20120313

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130927

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20131213

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20140313

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20140313

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20220223

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20230223

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20240226

Start annual number: 11

End annual number: 11